Mary Corey

1.4k total citations
21 papers, 1.0k citations indexed

About

Mary Corey is a scholar working on Pulmonary and Respiratory Medicine, Infectious Diseases and Surgery. According to data from OpenAlex, Mary Corey has authored 21 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Pulmonary and Respiratory Medicine, 4 papers in Infectious Diseases and 3 papers in Surgery. Recurrent topics in Mary Corey's work include Cystic Fibrosis Research Advances (17 papers), Neonatal Respiratory Health Research (6 papers) and Tracheal and airway disorders (3 papers). Mary Corey is often cited by papers focused on Cystic Fibrosis Research Advances (17 papers), Neonatal Respiratory Health Research (6 papers) and Tracheal and airway disorders (3 papers). Mary Corey collaborates with scholars based in Canada, United States and Ireland. Mary Corey's co-authors include Henry Levison, Michael R. Knowles, Lloyd J. Edwards, Henry Levison, Ronald Gold, Ian MacLusky, Dennis Gurwitz, Helen Heurter, Susan Carpenter and Laurence M. Blendis and has published in prestigious journals such as Hepatology, PEDIATRICS and The Journal of Infectious Diseases.

In The Last Decade

Mary Corey

20 papers receiving 996 citations

Peers

Mary Corey

PRM

EPIDE

SURGE

PHYSI

HEPAT

J. Angrill Spain

S. Ategbo France

Casper S. de Graaff Netherlands

Hans‐Georg Posselt Germany

Arvey I. Rogers United States

Ann Fieberg United States

William T. Harris United States

M B Mearns United Kingdom

Barry Linnane Ireland

Elisa A. Bradley United States

J. Angrill Spain

Mary Corey

986 ×1.2

PRM

534 ×2.5

EPIDE

98 ×0.6

SURGE

216 ×1.7

PHYSI

20 ×0.2

HEPAT

Citations per year, relative to Mary Corey Mary Corey (= 1×) peers J. Angrill

Countries citing papers authored by Mary Corey

Since Specialization

Citations

This map shows the geographic impact of Mary Corey's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mary Corey with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mary Corey more than expected).

Fields of papers citing papers by Mary Corey

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mary Corey. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mary Corey. The network helps show where Mary Corey may publish in the future.

Co-authorship network of co-authors of Mary Corey

This figure shows the co-authorship network connecting the top 25 collaborators of Mary Corey. A scholar is included among the top collaborators of Mary Corey based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mary Corey. Mary Corey is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Leahy, Timothy Ronan, Yvonne Yau, Eshetu G. Atenafu, et al.. (2011). Epidemiology of borderline oxacillin‐resistant Staphylococcus aureus in Pediatric cystic fibrosis. Pediatric Pulmonology. 46(5). 489–496. 21 indexed citations

Rose, Jennifer B., Lynda Ellis, Lorraine Martin, et al.. (2009). Does the Macroduct® collection system reliably define sweat chloride concentration in subjects with intermediate results?. Clinical Biochemistry. 42(12). 1260–1264. 10 indexed citations

Bhattacharjee, Rana, Susanne Schibli, P. Durie, et al.. (2006). 260 The natural history of liver disease in Cystic Fibrosis. Journal of Cystic Fibrosis. 5. S61–S61. 1 indexed citations

Wagener, Jeffrey S., Philip M. Farrell, & Mary Corey. (2001). A debate on why my state (province) should or should not conduct newborn screening for cystic fibrosis (14th Annual North American Cystic Fibrosis Conference)*. Pediatric Pulmonology. 32(5). 385–396. 13 indexed citations

Wilson, David C., Lynda Ellis, Julian Zielenski, et al.. (1998). Uncertainty in the diagnosis of cystic fibrosis: Possible role of in vivo nasal potential difference measurements. The Journal of Pediatrics. 132(4). 596–599. 46 indexed citations

Corey, Mary, Lloyd J. Edwards, Henry Levison, & Michael R. Knowles. (1997). Longitudinal analysis of pulmonary function decline in patients with cystic fibrosis. The Journal of Pediatrics. 131(6). 809–814. 275 indexed citations

Durie, P., Daina Kalnins, Miles C. Andrews, et al.. (1997). EFFECTIVENESS OF ADEKs® IN CYSTIC FIBROSIS AS A FAT SOLUBLE VITAMIN SUPPLEMENT, WITH SPECIAL ATTENTION TO VITAMIN K. Journal of Pediatric Gastroenterology and Nutrition. 25(4). 445–445. 1 indexed citations

Zielenski, Julian, D. Markiewicz, Keith Schappert, et al.. (1995). Identification of six mutations (R31L, 441delA, 681delC, 1461ins4, W1089R, E1104X) in the cystic fibrosis transmembrane conductance regulator (CFTR) gene. Human Mutation. 5(1). 43–47. 16 indexed citations

Wilschanski, Michael, Peter Chait, Judy Wade, et al.. (1995). Primary sclerosing cholangitis in 32 children: Clinical, laboratory, and radiographic features, with survival analysis. Hepatology. 22(5). 1415–1422. 132 indexed citations

10.

Reisman, Joseph, Mary Corey, Gerard J. Canny, et al.. (1992). Wheezing in Infants with Cystic Fibrosis: Clinical Course, Pulmonary Function, and Survival Analysis. PEDIATRICS. 90(5). 703–706. 13 indexed citations

11.

Kerem, Eitan, Mary Corey, Renato T. Stein, Ron S. Gold, & Henry Levison. (1990). Risk factors for Pseudomonas aeruginosa colonization in cystic fibrosis patients. The Pediatric Infectious Disease Journal. 9(7). 494–498. 35 indexed citations

12.

Corey, Mary, Peter Durie, David Moore, G. Forstner, & Henry Levison. (1989). Familial concordance of pancreatic function in cystic fibrosis. The Journal of Pediatrics. 115(2). 274–277. 47 indexed citations

13.

MacLusky, Ian, Ronald Gold, Mary Corey, & Henry Levison. (1989). Long‐term effects of inhaled tobramycin in patients with cystic fibrosis colonized with Pseudomonas aeruginosa. Pediatric Pulmonology. 7(1). 42–48. 128 indexed citations

14.

Kopelman, Hinda, et al.. (1989). Origins of chloride and bicarbonate secretory defects in the cystic fibrosis pancreas, as suggested by pancreatic function studies on control and CF subjects with preserved pancreatic function.. PubMed. 12(3). 207–11. 29 indexed citations

15.

Schmidt, Barbara, Haresh Kirpalani, Mary Corey, et al.. (1987). Coagulase-negative staphylococci as true pathogens in newborn infants. The Pediatric Infectious Disease Journal. 6(11). 1026–1031. 66 indexed citations

16.

Gold, Ronald, Susan Carpenter, Helen Heurter, Mary Corey, & Henry Levison. (1987). Randomized trial of ceftazidime versus placebo in the management of acute respiratory exacerbations in patients with cystic fibrosis. The Journal of Pediatrics. 111(6). 907–913. 63 indexed citations

17.

Corey, Mary, et al.. (1984). Sputum Bacteriology in Patients with Cystic Fibrosis in a Toronto Hospital During 1970-1981. The Journal of Infectious Diseases. 149(2). 283–283. 33 indexed citations

18.

Corey, Mary, et al.. (1983). Prognostic value of sweat-chloride levels in cystic fibrosis: a negative report.. PubMed. 64(6). 434–6. 1 indexed citations

19.

Gurwitz, Dennis, Mary Corey, & Henry Levison. (1980). Pulmonary function and bronchial reactivity in children after croup.. PubMed. 122(1). 95–9. 57 indexed citations

20.

Corey, Mary, et al.. (1979). Deficiency of serum carboxypeptidase B-like (anaphylatoxin inactivator, carboxypeptidase N) activity in sera from patients with cystic fibrosis.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 2(2-3). 99–103. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact